We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 3,874 results
  1. Cannabinoids for Acute Pain Management: Approaches and Rationale

    Purpose of the Review

    Acute pain management remains a challenge and postoperative pain is often undermanaged despite many available treatment options,...

    Mihai O. Botea, Lukas Andereggen, ... Carolina S. Romero in Current Pain and Headache Reports
    Article Open access 12 April 2024
  2. Synthetic cannabinoids impact on cognitive functions

    Background

    Synthetic cannabinoids SC are now becoming progressively popular among young people worldwide; little is known about their negative...

    Hanan Hany Elrassas, Yasser Abdel Razek Elsayed, ... Zeinab Mohamed El Nagar in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 14 November 2023
  3. Review: Cannabinoids as Medicinals

    Purpose of review

    There have been many debates, discussions, and published writings about the therapeutic value of cannabis plant and the hundreds of...

    Jag H. Khalsa, Gregory Bunt, ... Marc N. Potenza in Current Addiction Reports
    Article 07 September 2022
  4. Cannabinoids in Symptomatic Treatment for People with Multiple Sclerosis: a Systematic Review of Randomised Studies

    Purpose of Review

    The use of cannabinoid-based medicines in symptomatic treatment for people with multiple sclerosis (MS) is high. This review aimed...

    Graziella Filippini, Silvia Minozzi, ... Kerry Dwan in Current Physical Medicine and Rehabilitation Reports
    Article 18 July 2023
  5. Radiological findings in poisoning by synthetic cannabinoids adulterated with brodifacoum

    Objectives

    Severe coagulopathy due to consumption of synthetic cannabinoids adulterated with brodifacoum, a long-acting anticoagulant, is an emerging...

    Nitai Bar, Rebeca Lopez-Alonso, ... Sobhi Abadi in European Radiology
    Article 21 December 2023
  6. Death after smoking of fentanyl, 5F-ADB, 5F-MDMB-P7AICA and other synthetic cannabinoids with a bucket bong

    Purpose

    We report a case of a polydrug user who consumed various synthetic cannabinoids and fentanyl from a transdermal patch via a bucket bong....

    Merja A. Neukamm, Sebastian Halter, ... Marc Bartel in Forensic Toxicology
    Article Open access 10 June 2023
  7. The synthetic cannabinoids menace: a review of health risks and toxicity

    Synthetic cannabinoids (SCs) are chemically classified as psychoactive substances that target the endocannabinoid system in many body organs. SCs can...

    Ayman Alzu’bi, Fatimah Almahasneh, ... Raed M. Al-Zoubi in European Journal of Medical Research
    Article Open access 12 January 2024
  8. Cannabinoids as a Potential Alternative to Opioids in the Management of Various Pain Subtypes: Benefits, Limitations, and Risks

    Introduction

    Pain is a global phenomenon encompassing many subtypes that include neuropathic, musculoskeletal, acute postoperative, cancer, and...

    Samuel P. Ang, Shawn Sidharthan, ... Vwaire Orhurhu in Pain and Therapy
    Article Open access 13 January 2023
  9. Propylene glycol and Kolliphor as solvents for systemic delivery of cannabinoids via intraperitoneal and subcutaneous routes in preclinical studies: a comparative technical note

    Background

    Substance administration to laboratory animals necessitates careful consideration and planning in order to enhance agent distribution while...

    Kaveh Momenzadeh, Diana Yeritsyan, ... Ara Nazarian in Journal of Cannabis Research
    Article Open access 20 June 2023
  10. Unprescribed cannabinoids and multiple sclerosis: a multicenter, cross-sectional, epidemiological study in Lombardy, Italy

    Introduction

    Cannabinoids are approved for spasticity and pain in multiple sclerosis (MS). In 2017 the prevalence of current users in the Italian...

    Riccardo Giossi, Martina Mercenari, ... Valentina Torri Clerici in Journal of Neurology
    Article Open access 07 June 2024
  11. Semi-quantitative analysis of cannabinoids in hemp (Cannabis sativa L.) using gas chromatography coupled to mass spectrometry

    Background

    Hemp ( Cannabis sativa L.) is a producer of cannabinoids. These organic compounds are of increasing interest due to their potential...

    Luca De Prato, Matthew Timmins, ... Graham O’Hara in Journal of Cannabis Research
    Article Open access 22 September 2022
  12. Examining the role of cannabinoids on osteoporosis: a review

    Purpose

    Prior research studies have shown that the endocannabinoid system, influenced by CBD and THC, plays a role in bone remodeling. As both the...

    Grace Clouse, Samantha Penman, ... Panayotis K. Thanos in Archives of Osteoporosis
    Article 19 November 2022
  13. Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications

    Background

    Medical cannabinoids differ in their pharmacology and may have different treatment effects. We aimed to conduct a pharmacology-based...

    Ainhoa Bilbao, Rainer Spanagel in BMC Medicine
    Article Open access 19 August 2022
  14. Synthetic Cannabinoids and Cannabis: How the Patterns of Use Differ: Results from the European Web Survey on Drugs

    The aim of the current study is to assess if the patterns of use, socio-demographic characteristics, and use of other drugs differ among people who...

    Hugo López-Pelayo, Santiago Madero, ... João Matias in International Journal of Mental Health and Addiction
    Article 03 October 2022
  15. Clinical pattern of synthetic cannabinoids users in Upper Egypt: cross-sectional study

    Background

    There is an expanding use of new psychoactive substances containing synthetic cannabinoids in the last years. This study was conducted to...

    Wafaa M. Abdelmoneim, Nagwa M. Ghandour, ... Nora Z. Abdellah in Middle East Current Psychiatry
    Article Open access 30 March 2022
  16. Analyzing the Impact of Cannabinoids on the Treatment of Spinal Disorders

    Purpose of Review

    Cannabis is among the most used illicit substances globally, with medical applications, increased legalization, and shifting social...

    Rohan M. Shah, Anjay Saklecha, ... Srikanth N. Divi in Current Reviews in Musculoskeletal Medicine
    Article 08 February 2022
  17. Systematic Review and Meta-analysis Seem to Indicate that Cannabinoids for Chronic Primary Pain Treatment Have Limited Benefit

    Introduction

    The IASP ICD-11 chronic primary pain (CPP) definition includes 19 different painful conditions. In recent years, interest in the...

    Riccardo Giossi, Federica Carrara, ... Diego Fornasari in Pain and Therapy
    Article Open access 21 September 2022
  18. Multinational Association of Supportive Care in Cancer (MASCC) expert opinion/consensus guidance on the use of cannabinoids for gastrointestinal symptoms in patients with cancer

    Background

    Gastrointestinal symptoms are common in patients with cancer, whether related to treatment or a direct effect of the disease itself....

    Bryony Alderman, David Hui, ... Mellar Davis in Supportive Care in Cancer
    Article 16 December 2022
  19. Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer

    Introduction

    Several studies have shown anti-tumor effects of components present in cannabis in different models. Unfortunately, little is known about...

    Andrea M. Tomko, Erin G. Whynot, Denis J. Dupré in Journal of Cannabis Research
    Article Open access 22 July 2022
Did you find what you were looking for? Share feedback.